Genesco Inc. (GCO) PT Set at $33.00 by SunTrust Banks, Inc.

SunTrust Banks, Inc. set a $33.00 target price on Genesco Inc. (NYSE:GCO) in a research report released on Monday morning. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently issued reports on the company. UBS AG cut Genesco from a positive rating to a neutral rating in a report on Monday, August 28th. ValuEngine cut Genesco from a buy rating to a hold rating in a report on Friday, September 1st. Susquehanna Bancshares Inc reiterated a neutral rating and set a $29.00 target price (down previously from $43.00) on shares of Genesco in a report on Monday, August 28th. BidaskClub cut Genesco from a sell rating to a strong sell rating in a report on Monday, July 24th. Finally, Zacks Investment Research cut Genesco from a hold rating to a sell rating in a report on Wednesday, August 23rd. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have assigned a buy rating to the stock. The stock currently has an average rating of Hold and an average price target of $32.71.

Shares of Genesco (NYSE GCO) opened at 23.90 on Monday. Genesco has a 52-week low of $20.90 and a 52-week high of $72.00. The company’s 50-day moving average price is $25.07 and its 200-day moving average price is $35.30. The firm has a market cap of $476.06 million, a PE ratio of 6.71 and a beta of 1.36.

Genesco (NYSE:GCO) last released its earnings results on Thursday, August 31st. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.06) by ($0.04). The firm had revenue of $616.50 million for the quarter, compared to the consensus estimate of $626.93 million. Genesco had a return on equity of 7.36% and a net margin of 2.43%. Genesco’s revenue for the quarter was down 1.5% on a year-over-year basis. During the same quarter last year, the company posted $0.34 EPS. Equities analysts expect that Genesco will post $3.38 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was first posted by BBNS and is owned by of BBNS. If you are accessing this report on another website, it was stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this report can be accessed at https://baseballnewssource.com/markets/genesco-inc-gco-pt-set-at-33-00-by-suntrust-banks-inc/1719509.html.

In related news, Chairman Robert J. Dennis acquired 25,000 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was bought at an average price of $23.81 per share, for a total transaction of $595,250.00. Following the acquisition, the chairman now directly owns 224,935 shares of the company’s stock, valued at $5,355,702.35. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mimi Eckel Vaughn acquired 10,000 shares of the firm’s stock in a transaction dated Wednesday, September 6th. The stock was bought at an average price of $24.16 per share, with a total value of $241,600.00. Following the acquisition, the senior vice president now directly owns 87,140 shares in the company, valued at $2,105,302.40. The disclosure for this purchase can be found here. 3.30% of the stock is owned by company insiders.

A number of large investors have recently modified their holdings of the stock. Public Employees Retirement System of Ohio lifted its stake in Genesco by 16.9% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 4,278 shares of the company’s stock valued at $145,000 after purchasing an additional 618 shares during the last quarter. Verition Fund Management LLC lifted its stake in Genesco by 391.7% in the 2nd quarter. Verition Fund Management LLC now owns 18,683 shares of the company’s stock valued at $633,000 after purchasing an additional 14,883 shares during the last quarter. Tower Research Capital LLC TRC acquired a new stake in Genesco in the 2nd quarter valued at about $144,000. Arrowstreet Capital Limited Partnership lifted its stake in Genesco by 3.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 99,299 shares of the company’s stock valued at $3,366,000 after purchasing an additional 3,199 shares during the last quarter. Finally, State Street Corp lifted its stake in Genesco by 12.4% in the 2nd quarter. State Street Corp now owns 648,235 shares of the company’s stock valued at $21,977,000 after purchasing an additional 71,541 shares during the last quarter. Institutional investors and hedge funds own 94.38% of the company’s stock.

Genesco Company Profile

Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.

Analyst Recommendations for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston’s Dallas Keuchel Could Make Relief Appearance in Game 7
Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation


Leave a Reply

 
© 2006-2017 BBNS.